<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-5NYQ57HG</identifier><date>2014</date><creator>Mavri, Alenka</creator><creator>Štalc, Monika</creator><relation>documents/doc/5/URN_NBN_SI_doc-5NYQ57HG_001.pdf</relation><relation>documents/doc/5/URN_NBN_SI_doc-5NYQ57HG_001.txt</relation><format format_type="issue">2</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 129-136</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">1504684</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-5NYQ57HG</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antikoagulacijsko zdravljenje</subject><subject language_type_id="slv">atrijska fibrilacija</subject><subject language_type_id="eng">drug</subject><subject language_type_id="slv">krvavitev</subject><subject language_type_id="slv">venska trombembolija</subject><subject language_type_id="slv">zdravila</subject><title>New oral anticoagulants</title><title>Zdravljenje z novimi peroralnimi antikoagulacijskimi zdravili</title></Record>